Treatment of shoulder pain in patients of paralysis due to stroke under ultrasound guidance by bupivacaine and radiofrequency ablation

COMPARISON OF ULTRASOUND GUIDED PULSED RADIOFREQUENCY ABLATION AND BUPIVACAINE BLOCK OF SUPRASCAPULAR NERVE IN REDUCTION OF PAIN AND DISABILITY IN HEMIPLEGIC SHOULDER PAIN: A RANDOMIZED CONTROLLED STUDY

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/10/021733

Enrollment

Registered

2019-10-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G819- Hemiplegia, unspecified

Interventions

Intervention1: ultrasound guided pulsed radiofrequency ablation of suprascapular nerve: The patient in sitting position, skin cleaning with 10% betadine and spirit solution. Suprascapular notch will b

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed as acute stroke within the previous 12 months with hemiplegic shoulder pain. Pain severity with minimum score of 5 based on 10 scale VAS. Willingness to comply with treatment and follow-up assessments.

Exclusion criteria

Exclusion criteria: 1. Cognitive deficit that precluded patients from reliably using subjective outcome measures scales [Mini Mental State Examination] 2. Allergy to proposed injection agents (lidocaine and Bupivacaine) 3. Degenerative changes at the glenohumeral joint as shown by a standard anteroposterior radiograph 4. Any recent febrile or infectious disease (systemic & local) 5. History of any malignancy (including hematologic and non-hematologic malignancies) 6. Previous history of systemic inflammatory joint disease like rheumatoid arthritis, gout, etc 7. Metabolic or systemic disease like ischemic heart disease, hepatitis, uncontrolled diabetes mellitus 8. Any trauma, fracture, bony malformation or dislocation of shoulder 9. History of autoimmune and hematological disorders 10. Intra or periarticular steroid injection to shoulder in previous 2 months 11. Platelet counts of less than 150,000 per micro liter 12. Cardiac arrhythmia or a pacemaker 13. Hemorrhagic stroke

Design outcomes

Primary

Measure	Time frame
1. Visual Analog Scale (VAS) 2. Shoulder Range Of Motion (ROM) Timepoint: At 1st, 4th, 12th and 24th week	—

Secondary

Measure	Time frame
Shoulder Pain And Disability Index (SPADI)Timepoint: 1, 4, 12 and 24 weeks	—

Countries

India

Contacts

Public ContactChandrakant Pilania

Regional Institute of Medical Sciences

drnilalong@gmail.com8209178449

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026